- Home
- CRAI vs ELVN Comparison
CRAI vs ELVN Comparison
Compare CRAI & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRAI
- ELVN
- Stock Information
- Founded
- CRAI 1965
- ELVN 2016
- Country
- CRAI United States
- ELVN United States
- Employees
- CRAI N/A
- ELVN N/A
- Industry
- CRAI Other Consumer Services
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- CRAI Consumer Discretionary
- ELVN Health Care
- Exchange
- CRAI Nasdaq
- ELVN Nasdaq
- Market Cap
- CRAI 1.3B
- ELVN 1.2B
- IPO Year
- CRAI 1998
- ELVN 2020
- Fundamental
- Price
- CRAI $203.35
- ELVN $18.50
- Analyst Decision
- CRAI Buy
- ELVN Strong Buy
- Analyst Count
- CRAI 1
- ELVN 5
- Target Price
- CRAI $228.00
- ELVN $41.20
- AVG Volume (30 Days)
- CRAI 78.9K
- ELVN 459.4K
- Earning Date
- CRAI 10-30-2025
- ELVN 11-12-2025
- Dividend Yield
- CRAI 0.99%
- ELVN N/A
- EPS Growth
- CRAI 44.21
- ELVN N/A
- EPS
- CRAI 8.27
- ELVN N/A
- Revenue
- CRAI $712,913,000.00
- ELVN N/A
- Revenue This Year
- CRAI $9.01
- ELVN N/A
- Revenue Next Year
- CRAI $4.26
- ELVN $25.00
- P/E Ratio
- CRAI $23.98
- ELVN N/A
- Revenue Growth
- CRAI 9.28
- ELVN N/A
- 52 Week Low
- CRAI $152.57
- ELVN $13.30
- 52 Week High
- CRAI $214.01
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- CRAI 63.59
- ELVN 39.08
- Support Level
- CRAI $191.56
- ELVN $18.80
- Resistance Level
- CRAI $198.89
- ELVN $21.30
- Average True Range (ATR)
- CRAI 4.77
- ELVN 1.08
- MACD
- CRAI 0.35
- ELVN -0.13
- Stochastic Oscillator
- CRAI 96.60
- ELVN 12.23
About CRAI CRA International Inc.
CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.